BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 231639)

  • 1. The mode of action alginic acid compound in the reduction of gastroesophageal reflux.
    Malmud LS; Charkes ND; Littlefield J; Reilley J; Stern H; Rosenberg R; Fisher RS
    J Nucl Med; 1979 Oct; 20(10):1023-8. PubMed ID: 231639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of gastro-esophageal reflux using a potable gaviscon suspension].
    Guerre J; Neuman M; Bouchet J
    Med Chir Dig; 1982; 11(4):289-95. PubMed ID: 6287126
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of gaviscon and metoclopramide in gastroesophageal reflux in children.
    Forbes D; Hodgson M; Hill R
    J Pediatr Gastroenterol Nutr; 1986; 5(4):556-9. PubMed ID: 3016226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Algicon in the management of gastro-oesophageal reflux.
    Lambert JR; Korman MG; Nicholson L
    Br J Clin Pract Suppl; 1989 Feb; 66():56-8; discussion 61-4. PubMed ID: 2556177
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative study of Algicon versus Gaviscon in symptomatic gastro-oesophageal reflux.
    Ward AE
    Br J Clin Pract Suppl; 1989 Feb; 66():52-5; discussion 61-4. PubMed ID: 2556176
    [No Abstract]   [Full Text] [Related]  

  • 6. [Alginate-containing preparation gaviscon for patients with gastroesophaginal reflux complicated with chronic pancreatitis: pathogenetic substantiation of clinical use prospects].
    Uspenskiĭ IuP; Pakhomova IG; Bubiakina VN
    Eksp Klin Gastroenterol; 2008; (1):96-101. PubMed ID: 19145860
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gastroesophageal reflux. Results of a multicenter study of 170 patients on the therapeutic value of the Gaviscon drinkable suspension].
    Chevrel B
    Med Chir Dig; 1980; 9(6):535-9. PubMed ID: 6259459
    [No Abstract]   [Full Text] [Related]  

  • 8. [pH gradient support and antacid action of gastroesophageal coating agents. In vitro pharmacologic study using a model of "the artificial stomach"].
    Vatier J; Vitre MT; Vallot T; Mignon M
    Gastroenterol Clin Biol; 1990; 14(5):414-22. PubMed ID: 2163935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative intragastric pH profile of Algicon versus Gaviscon.
    Stoddard CJ; Morgan GE
    Br J Clin Pract Suppl; 1989 Feb; 66():29-34; discussion 35-6. PubMed ID: 2556174
    [No Abstract]   [Full Text] [Related]  

  • 10. Review article: alginate-raft formulations in the treatment of heartburn and acid reflux.
    Mandel KG; Daggy BP; Brodie DA; Jacoby HI
    Aliment Pharmacol Ther; 2000 Jun; 14(6):669-90. PubMed ID: 10848650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroesophageal scintigraphy.
    Malmud LS; Fisher RS
    Gastrointest Radiol; 1980 Aug; 5(3):195-204. PubMed ID: 7418989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined cimetidine-alginate antacid therapy versus single agent treatment for reflux oesophagitis: results of prospective double-blind randomised clinical trial.
    Eriksen CA; Cheadle WG; Cranford CA; Cuschieri A
    Ann Chir Gynaecol; 1988; 77(4):133-7. PubMed ID: 2855391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between cisapride and Gaviscon with Carobel in the treatment of gastro-oesophageal reflux in infancy.
    Greally P; Hampton FJ; MacFadyen UM; Simpson H
    Ir Med J; 1992; 85(4 Suppl):14. PubMed ID: 1490841
    [No Abstract]   [Full Text] [Related]  

  • 14. Alginic acid decreases postprandial upright gastroesophageal reflux. Comparison with equal-strength antacid.
    Castell DO; Dalton CB; Becker D; Sinclair J; Castell JA
    Dig Dis Sci; 1992 Apr; 37(4):589-93. PubMed ID: 1551350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gaviscon in reflux symptoms. Results of a drug monitoring study].
    Hutt HJ; Tauber O; Flach D
    Fortschr Med; 1990 Oct; 108(31):598-600. PubMed ID: 2258131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gaviscon and gastroesophageal reflux in children.
    Buts JP; Leclercq V
    J Pediatr Gastroenterol Nutr; 1987; 6(3):482-3. PubMed ID: 2828595
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic procedures in gastroesophageal reflux disease].
    Tytgat GN
    Z Gastroenterol; 1986 Sep; 24 Suppl 2():40-4. PubMed ID: 2877526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heartburn and regurgitation in pregnancy. Efficacy and innocuousness of treatment with Gaviscon suspension].
    Uzan M; Uzan S; Sureau C; Richard-Berthe C
    Rev Fr Gynecol Obstet; 1988; 83(7-9):569-72. PubMed ID: 2848305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gaviscon for gastro-oesophageal reflux in infants: a poorly effective treatment?
    Cresi F; Savino F; Marinaccio C; Silvestro L
    Arch Dis Child; 2006 Jan; 91(1):93. PubMed ID: 16371388
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative study of Algicon suspension and magnesium trisilicate mixture in the treatment of reflux dyspepsia of pregnancy.
    Lang GD; Dougall A
    Br J Clin Pract Suppl; 1989 Feb; 66():48-51; discussion 61-4. PubMed ID: 2556175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.